Arthritis

Mechanistic insights into how Zoledronate attenuates Arthritis: Zoledronate (also known as Zoledronic acid) (brand name: Reclast, Zometa and others), used to treat bone diseases, including osteoporosis, high blood calcium & bone breakdown due to cancer, and Paget’s disease of bone, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, prevents fracture, and inhibits pathological features associated with arthritis, via up-regulation of its target genes, 17/August/2019, 6.12 pm
Mechanistic insights into how Zoledronate attenuates Arthritis: Zoledronate (also known as Zoledronic acid) (brand name: Reclast, Zometa and others), used to treat bone diseases, including osteoporosis, high blood calcium & bone breakdown due to cancer, and Paget’s disease of bone, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, prevents fracture, and inhibits pathological features associated with arthritis, via up-regulation of its target genes, 17/August/2019, 6.12 pm 960 720

Introduction: What they say A study from Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany shows that “Resolution of inflammation by…

read more

Mechanistic insights into how Rituximab attenuates Arthritis: Rituximab (brand name: Ritusan), used to treat bone-related disorders, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis, via up-regulation of its target genes, 13/August/2019, 12.24 am
Mechanistic insights into how Rituximab attenuates Arthritis: Rituximab (brand name: Ritusan), used to treat bone-related disorders, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis, via up-regulation of its target genes, 13/August/2019, 12.24 am 960 720

Introduction: What they say A study from Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany shows that “Resolution of inflammation by…

read more

Mechanistic insights into how Alendronate attenuates Arthritis: Alendronate (brand name:  Fosamax), used to treat osteoarthritis and paget’s disease of bone, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis, via up-regulation of its target genes, 10/August/2018, 6.02 pm
Mechanistic insights into how Alendronate attenuates Arthritis: Alendronate (brand name:  Fosamax), used to treat osteoarthritis and paget’s disease of bone, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis, via up-regulation of its target genes, 10/August/2018, 6.02 pm 960 720

Introduction: What they say A study from Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany shows that “Resolution of inflammation by…

read more

Mechanistic insights into how  Tofacitinib attenuates rheumatoid arthritis:  Tofacitinib (brand name: Xeljanz), used to treat  rheumatoid/psoriatic arthritis and ulcerative colitis, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis via up-regulation of its target genes, 5/August/2018, 1.29 am
Mechanistic insights into how  Tofacitinib attenuates rheumatoid arthritis:  Tofacitinib (brand name: Xeljanz), used to treat  rheumatoid/psoriatic arthritis and ulcerative colitis, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis via up-regulation of its target genes, 5/August/2018, 1.29 am 960 720

Introduction: What they say A study from Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany shows that “Resolution of inflammation by…

read more

Neuropeptide Y-based therapy for inflammation and arthritis: Neuropeptide Y, a  36 amino-acid neuropeptide that plays a role in the regulation of food intake, storage of food, anxiety, stress, perception of pain and others, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis via up-regulation of its target genes, 29/April/2019, 3.10 pm
Neuropeptide Y-based therapy for inflammation and arthritis: Neuropeptide Y, a  36 amino-acid neuropeptide that plays a role in the regulation of food intake, storage of food, anxiety, stress, perception of pain and others, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis via up-regulation of its target genes, 29/April/2019, 3.10 pm 960 720

Introduction: What they say A study from Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany shows that “Resolution of inflammation by…

read more

Have oats to stay protected against Arthritis: Oat Avenanthramide A-based therapy for inflammation and arthritis: Avenanthramide A, found in oats, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis via up-regulation of its target genes, 15/April/2019, 3.35 pm
Have oats to stay protected against Arthritis: Oat Avenanthramide A-based therapy for inflammation and arthritis: Avenanthramide A, found in oats, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis via up-regulation of its target genes, 15/April/2019, 3.35 pm 960 720

Introduction: What they say A study from Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany shows that “Resolution of inflammation by…

read more
Start Typing